Clinical Challenges in HIV Treatment and Prevention

Moderated by Princy N. Kumar, MD, a panel of HIV experts discusses how the newest evidence on preventive medicine guides managing HCV sexual transmission in a young MSM on PrEP, prescribing PrEP for a male PWID and his female partner, and reducing cardiovascular risk in a middle-aged woman with stable virologic suppression. 
W. David Hardy, MD
Program Director
Princy N. Kumar, MD
person default
Jaimie P. Meyer, MD, MS, FACP
Babafemi Taiwo, MBBS
Released: June 18, 2018 Expiration: No longer available for credit

Related Content

Expert commentary on COVID-19 risk in persons with HIV and the best strategies to minimize risk

Renslow Sherer, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: October 12, 2020 Expired: October 11, 2021

CCO commentary by Jennifer Cocohoba, PharmD, on how to avoid polypharmacy in aging patients with HIV

Jennifer Cocohoba Headshot Jennifer Cocohoba, PharmD Released: October 12, 2020

CCO slides on ending the HIV epidemic in the United States via expanded testing, enhanced linkage to care, and rapid response to potential outbreaks

Lisa K. Fitzpatrick, MD, MPH, MPA David Malebranche, MD, MPH Released: October 7, 2020

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020


Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Educational grants provided by
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.